Cancer prevention and control: Alarming challenges in China

National Science Review

Volumn 3, Issue 1, 2016, Pages 117-127

  Bode, Ann M ^a   Dong, Zigang ^a   Wang, Hongyang ^b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b National Scientific Centre for Liver Cancer   (China)

^c Eastern Hepatobiliary Surgery Hospital   (China)

Author keywords

Alcohol; Cancer incidence; Cancer preventioncover date; Dietary deficiencies; Environmental pollution; Infection caused cancers; Obesity; Occupational carcinogens; Tobacco use and control

Indexed keywords

EID: 84963836342     PISSN: 20955138     EISSN: 2053714X     Source Type: Journal    
DOI: 10.1093/nsr/nwv054     Document Type: Review

References (132)

1. Jian, W, Chan, KY and Reidpath, DD et al. China's rural-urban care gap shrank for chronic disease patients, but inequities persist. Health Aff 2010; 29: 2189-96
2. Zhao, P, Dai, M and Chen,Wet al. Cancer trends in China. Jpn J Clin Oncol 2010; 40: 281-5
3. Mortality, GBD. Causes of Death C. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385: 117-71
4. Lee, L. The current state of public health in China. Annu Rev Public Health 2004; 25: 327-39
5. Yang, G, Wang, Y and Zeng, Y et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2013; 381: 1987-2015
6. Ouyang, Y. China tackles illness-led poverty as financing gap grows. Lancet Oncol 2013; 14 :19
7. Bode, AM, Cao, Y and Dong, Z. Update on cancer prevention research in the United States and China: the 2009 China-U.S. forum on frontiers of cancer research. Cancer Prevent Res 2010; 3 :1630-7
8. Chen, Y, Ebenstein, A and Greenstone, M et al. Evidence on the impact of sustained exposure to air pollution on life expectancy from China's Huai River policy. Proc Natl Acad Sci USA 2013; 110: 12936-41
9. Chan, CK and Yao, X. Air pollution in mega cities in China. Atmos Environ 2008; 42: 1-42
10. Zhang, J, Mauzerall, DL and Zhu, T et al. Environmental health in China: progress towards clean air and safe water. Lancet 2010; 375: 1110-9
11. Alcorn, T. China's skies: a complex recipe for pollution with no quick fix. Lancet 2013; 381: 1973-4
12. Rock, M and Angel, D. Grow first, clean up later? Industrial transformation in East Asia. Environment 2007; 49: 8-19
13. Loomis, D, Grosse, Y and Lauby-Secretan, B et al. The carcinogenicity of outdoor air pollution. Lancet Oncol 2013; 14: 1262-3
14. Clapp, RW, Howe, GK and Jacobs, MM. Environmental and occupational causes of cancer: a call to act on what we know. Biomed Pharmacother 2007; 61: 631-9
15. Bearer, CF. How are children different from adults? Environ Health Perspect 1995; 103(Suppl 6): 7-12
16. Boffetta, P and Nyberg, F. Contribution of environmental factors to cancer risk. Br Med Bull 2003; 68: 71-94
17. Watts, J. China's environmental health challenges. Lancet 2008; 372: 1451-2
18. Wang, JB, Jiang, Y and Liang, H et al. Attributable causes of cancer in China. Ann Oncol/ESMO 2012; 23: 2983-9
19. Unger, N, Bond, TC and Wang, JS et al. Attribution of climate forcing to economic sectors. Proc Natl Acad Sci USA 2010; 107: 3382-7
20. Brauer, M, Amann, M and Burnett, RT et al. Exposure assessment for estimation of the global burden of disease attributable to outdoor air pollution. Environ Sci Technol 2012; 46: 652-60
21. Krewski, D, Jerrett, M and Burnett, RT et al. Extended followup and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality. Res Rep 2009; 140: 5-114
22. Raaschou-Nielsen, O, Andersen, ZJ and Beelen, R et al. Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol 2013; 14: 813-22
23. Turner, MC, Krewski, D and Pope, CA, 3rd et al. Long-term ambient fine particulate matter air pollution and lung cancer in a large cohort of never-smokers. Am J Resp Crit Care 2011; 184: 1374-81
24. Pope, CA, 3rd, Burnett, RT and Thun, MJ et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002; 287: 1132-41
25. Gao, H. Chinese Government admits existence of cancer villages. Lancet Oncol 2013; 14: 284
26. Epplein, M, Schwartz, SM and Potter, JD et al. Smokingadjusted lung cancer incidence among Asian-Americans (United States). Cancer Causes Control 2005; 16: 1085-90
27. Mu, L, Liu, L and Niu, R et al. Indoor air pollution and risk of lung cancer among Chinese female non-smokers. Cancer Causes Control 2013; 24: 439-50
28. Jemal, A, Bray, F and Center, MM et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90
29. Kim, C, Gao, YT and Xiang, YB et al. Home kitchen ventilation, cooking fuels, and lung cancer risk in a prospective cohort of never smoking women in Shanghai, China. Int J Cancer 2015; 136: 632-8
30. Zhou, Z, Dionisio, KL and Arku, RE et al. Household and community poverty, biomass use, and air pollution in Accra, Ghana. Proc Natl Acad Sci USA 2011; 108: 11028-33
31. Zhang, JJ and Smith, KR. Household air pollution from coal and biomass fuels in China: measurements, health impacts, and interventions. Environ Health Perspect 2007; 115: 848-55
32. Armstrong, B, Hutchinson, E and Unwin, J et al. Lung cancer risk after exposure to polycyclic aromatic hydrocarbons: a review and meta-analysis. Environ Health Perspect 2004; 112: 970-8
33. Lan, Q, Chapman, RS and Schreinemachers, DM et al. Household stove improvement and risk of lung cancer in Xuanwei, China. J Natl Cancer Inst 2002; 94: 826-35
34. Zhang, XL, Bing, Z and Xing, Z et al. Research and control of well water pollution in high esophageal cancer areas. World J Gastroenterol 2003; 9: 1187-90
35. Food safety in China: a long way to go. Lancet 2012; 380: 75
36. Zhuang, P, McBride, MB and Xia, H et al. Health risk from heavy metals via consumption of food crops in the vicinity of Dabaoshan mine, South China. Sci Total Environ 2009; 407: 1551-61
37. Abnet, CC. Carcinogenic food contaminants. Cancer Invest 2007; 25: 189-96
38. Ross, RK, Yuan, JM and Yu, MC et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339: 943-6
39. Ren, ZF, Liu, WS and Qin, HD et al. Effect of family history of cancers and environmental factors on risk of nasopharyngeal carcinoma in Guangdong, China. Cancer Epidemiol 2010; 34: 419-24
40. Zou, XN, Lu, SH and Liu, B. Volatile N-nitrosamines and their precursors in Chinese salted fish-a possible etological factor for NPC in china. Int J Cancer 1994; 59: 155-8
41. Borak, J and Hosgood, HD. Seafood arsenic: implications for human risk assessment. Regul Toxicol Pharmacol 2007; 47: 204-12
42. Wu, X, Gao, M and Wang, L et al. The arsenic content in marketed seafood and associated health risks for the residents of Shandong, China. Ecotoxicol Environ Saf 2014; 102: 168-73
43. Wang, M, Webber, M and Finlayson, B et al. Rural industries and water pollution in China. J Environ Manage 2008; 86: 648-59
44. Liu, L. Impacts of market location on rural poverty and income inequality in China. Chin Econ 2006; 39: 64-78
45. Zhou, Y, Wang, H and Chen, Y et al. Environmental and food contamination with plasticisers in China. Lancet 2011; 378: e4
46. Qiao, G, Guo, T and Klein, KK. Melamine and other food safety and health scares in China: comparing households with and without young children. Food Control 2012; 26: 378-86
47. Smith, KR. Smoked out: the health hazards of burning coal. Lancet 2013; 381: 1979
48. Glynn, T, Seffrin, JR and Brawley, OW et al. The globalization of tobacco use: 21 challenges for the 21st century. CA: a cancer journal for clinicians 2010; 60: 50-61
49. Yang, L, Sung, HY and Mao, Z et al. Economic costs attributable to smoking in China: update and an 8-year comparison, 2000-2008. Tob Control 2011; 20: 266-72
50. Wang, JB, Jiang, Y and Wei, WQ et al. Estimation of cancer incidence and mortality attributable to smoking in China. Cancer Causes Control 2010; 21: 959-65
51. Siemiatycki, J, Richardson, L and Straif, K et al. Listing occupational carcinogens. Environ Health Perspect 2004; 112: 1447-59
52. Liang, YX, Su, Z and Wu, WA et al. New trends in the development of occupational exposure limits for airborne chemicals in China. Regul Toxicol Pharmacol 2003; 38: 112-23
53. Hosgood, HD, 3rd, Zhang, L and Tang, X et al. Occupational exposure to formaldehyde and alterations in lymphocyte subsets. Am J Ind Med 2013; 56: 252-7
54. Liu, Y, Steenland, K and Rong, Y et al. Exposure-response analysis and risk assessment for lung cancer in relationship to silica exposure: a 44-year cohort study of 34,018 workers. Am J Epidemiol 2013; 178: 1424-33
55. Zhang, L, Blot, WJ and You, WC et al. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Cancer Epidemiol Biomark Prev 1996; 5: 627-30
56. Ma, JL, You, WC and Gail, MH et al. Helicobacter pylori infection and mode of transmission in a population at high risk of stomach cancer. Int J Epidemiol 1998; 27: 570-3
57. You, WC, Brown, LM and Zhang, L et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006; 98: 974-83
58. Ma, JL, Zhang, L and Brown, LM et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 2012; 104: 488-92
59. Wong, BC, Zhang, L and Ma, JL et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut 2012; 61: 812-8
60. Checkoway, H, Lundin, JI and Costello, S et al. Reply to Comment on: 'Possible pro-carcinogenic association of endotoxin on lung cancer among Shanghai women textile workers'. Br J Cancer 2015; 112: 1840-1
61. Fischbach, LA, van Zanten, S and Dickason, J. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Aliment Pharmacol Ther 2004; 20: 1071-82
62. Gatta, L, Zullo, A and Perna, F et al. A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses. Aliment Pharmacol Ther 2005; 22: 45-9
63. Gisbert, JP, Gonzalez, L and Calvet, X. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication. Helicobacter 2005; 10: 157-71
64. Graham, DY, Hammoud, F and El-Zimaity, HM et al. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Aliment Pharmacol Ther 2003; 17: 1229-36
65. Qasim, A, Sebastian, S and Thornton, O et al. Rifabutin-and furazolidonebased Helicobacter pylori eradication therapies after failure of standard firstand second-line eradication attempts in dyspepsia patients. Aliment Pharmacol Ther 2005; 21: 91-6
66. Wang, FS, Fan, JG and Zhang, Z et al. The global burden of liver disease: the major impact of China. Hepatology 2014; 60: 2099-108
67. Chen, JG ed. Cancer in Qidong, China (1972-2011). Beijing: Military Medical Scientific Press; 2013
68. Sun, Z, Ming, L and Zhu, X et al. Prevention and control of hepatitis B in China. J Med Virol 2002; 67: 447-50
69. Luo, Z, Li, L and Ruan, B. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Int J Infect Dis 2012; 16: e82-8
70. Qu, CF, Chen, TY and Fan, CS et al. Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial. PLoS Med 2014; 11: e1001774
71. Bray, F, Ren, JS and Masuyer, E et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013; 132: 1133-45
72. Zhao, FH, Lin, MJ and Chen, F et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol 2010; 11: 1160-71
73. Epstein, MA, Achong, BG and Barr, YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 283: 702-3
74. Tao, Q and Chan, AT. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 2007; 9: 1-24
75. Qin, HD, Shugart, YY and Bei, JX et al. Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma. Cancer Res 2011; 71: 3000-8
76. Xu, FH, Xiong, D and Xu, YF et al. An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein-Barr virus activation. J Natl Cancer Inst 2012; 104: 1396-410
77. Cohen, JI, Fauci, AS, Varmus, H and Nabel, GJ. Epstein-Barr virus: an important vaccine target for cancer prevention. Sci Transl Med 2011; 3: 107fs7
78. Young, LS and Rickinson, AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004; 4: 757-68
79. Holmes, D. The cancer-virus cures. Nat Med 2014; 20: 571-4
80. Rehm, J, Samokhvalov, AV and Shield, KD. Global burden of alcoholic liver diseases. J Hepatol 2013; 59: 160-8
81. Boffetta, P and Hashibe, M. Alcohol and cancer. Lancet Oncol 2006; 7: 149-56
82. Li, YM, Fan, JG and Wang, BY et al. Guidelines for the diagnosis and management of alcoholic liver disease: update 2010. J Dig Dis 2011; 12: 45-50
83. Zhou, L, Conner, KR and Phillips, MR et al. Epidemiology of alcohol abuse and dependence in rural chinese men. Alcohol Clin Exp Res 2009; 33: 1770-6
84. Chen, GH, Yang, Y and Lu, MQ et al. Liver transplantation for end-stage alcoholic liver disease: a single-center experience from mainland China. Alcohol 2010; 44: 217-21
85. Liang, H, Wang, J and Xiao, H et al. Estimation of cancer incidence and mortality attributable to alcohol drinking in China. BMC Public Health 2010; 10: 730
86. Li, Y, Yang, H and Cao, J. Association between alcohol consumption and cancers in the Chinese population-a systematic review and meta-analysis. PLoS One 2011; 6: e18776
87. Guo, YM, Wang, Q and Liu, YZ et al. Genetic polymorphisms in cytochrome P4502E1, alcohol and aldehyde dehydrogenases and the risk of esophageal squamous cell carcinoma in Gansu Chinese males. World J Gastroenterol 2008; 14: 1444-9
88. Liu, TT, Fang, Y and Xiong, H et al. A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China. World J Gastroenterol 2008; 14: 3059-63
89. Wang, Z, Tang, L and Sun, G et al. Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China. BMC Cancer 2006; 6: 287
90. Wei, YS, Lu, JC and Wang, L et al. Risk factors for sporadic colorectal cancer in southern Chinese. World J Gastroenterol 2009; 15: 2526-30
91. Zhang, P, Di, JZ and Zhu, ZZ et al. Association of transforming growth factorbeta 1 polymorphisms with genetic susceptibility to TNM stage I or II gastric cancer. Jpn J Clin Oncol 2008; 38: 861-6
92. Cheng, KK, Duffy, SW and Day, NE et al. Stopping drinking and risk of oesophageal cancer. BMJ 1995; 310: 1094-7
93. Hill, MJ. Changes and developments in cancer prevention. J R Soc Health 2001; 121: 94-7
94. Doll, R and Peto, R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1191-308
95. Yang, CS, Miao, J and Yang, W et al. Diet and vitamin nutrition of the high esophageal cancer risk population in Linxian, China. Nutr Cancer 1982; 4: 154-64
96. Martinez, ME, Jacobs, ET and Baron, JA et al. Dietary supplements and cancer prevention: balancing potential benefits against proven harms. J Natl Cancer Inst 2012; 104: 732-9
97. Potter, JD. The failure of cancer chemoprevention. Carcinogenesis 2014; 35: 974-82
98. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-35
99. Omenn, GS, Goodman, G and Thornquist, M et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res 1994; 54: 2038s-43s
100. Albanes, D, Heinonen, OP and Taylor, PR et al. Alpha-Tocopherol and betacarotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996; 88: 1560-70
101. Omenn, GS, Goodman, GE and Thornquist, MD et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-5
102. Neuhouser, ML, Patterson, RE and Thornquist,MD et al. Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the betacarotene and retinol efficacy trial (CARET). Cancer Epidemiol Biomark Prev 2003; 12: 350-8
103. Virtamo, J, Pietinen, P and Huttunen, JK et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 2003; 290: 476-85
104. Lippman, SM, Klein, EA and Goodman, PJ et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009; 301: 39-51
105. Hardy, G, Hardy, I and McElroy, B. Nutraceuticals: a pharmaceutical viewpoint: I. Curr Opin Clin Nutr Metab Care 2002; 5: 671-7
106. Correa-Velez, I, Clavarino, A and Eastwood, H. Surviving, relieving, repairing, and boosting up: reasons for using complementary/alternative medicine among patients with advanced cancer: a thematic analysis. J Palliat Med 2005; 8: 953-61
107. Yeung, KS, Gubili, J and Cassileth, B. Evidence-based botanical research: applications and challenges. Hematol Oncol Clin North Am 2008; 22: 661-70
108. Shahrokh, LE, Lukaszuk, JM and Prawitz, AD. Elderly herbal supplement users less satisfied with medical care than nonusers. J Am Diet Assoc 2005; 105: 1138-40
109. Algra, AM and Rothwell, PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 2012; 13: 518-27
110. Chan, AT, Arber, N and Burn, J et al. Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res 2012; 5: 164-78
111. Cook, NR, Lee, IM and Zhang, SM et al. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Int Med 2013; 159: 77-85
112. Cuzick, J, Thorat, MA and Bosetti, C et al. Estimates of benefits and harms of prophylactic use of aspirin in the general population. Ann Oncol/ESMO 2015; 26: 47-57
113. Fink, SP, Yamauchi,Mand Nishihara, R et al. Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD). Sci Transl Med 2014; 6: 233re2
114. Huang, ES, Strate, LL and Ho,WWet al. Long-term use of aspirin and the risk of gastrointestinal bleeding. Am J Med 2011; 124: 426-33
115. Rothwell, PM, Price, JF and Fowkes, FG et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 2012; 379: 1602-12
116. Williams, RW. The Natural History of Cancer With Special Reference to Its Causation and Prevention. London: W. Heinemann, 1908
117. Lambe, W. Water and Vegetable Diet in Consumption, Scrofulla, Cancer, Asthma, and Other Chronic Diseases. New York: Fowlers and Wells, 1854
118. Ng,M, Fleming, T and Robinson,Met al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766-81
119. Renehan, AG, Tyson,Mand Egger,Met al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-78
120. Husson, O, Mols, F and Ezendam, NP et al. Health-related quality of life is associated with physical activity levels among colorectal cancer survivors: a longitudinal, 3-year study of the PROFILES registry. J Cancer Surviv 2015; 9: 472-80
121. Wu, CY, Hu, HY and Chou, YC et al. The association of physical activity with all-cause, cardiovascular, and cancer mortality among older adults. Prev Med 2015; 72: 23-9
122. Arem, H, Pfeiffer, RM and Engels, EA et al. Pre-and postdiagnosis physical activity, television viewing, and mortality among patients with colorectal cancer in the National Institutes of Health-AARP Diet and Health Study. J Clin Oncol 2015; 33: 180-8
123. Xu, Y, Wang, L and He, J et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013; 310: 948-59
124. Du, T, Sun, X and Yin, P et al. Increasing trends in central obesity among Chinese adults with normal body mass index, 1993-2009. BMC Public Health 2013; 13: 327
125. Fan, JG, Zhu, J and Li, XJ et al. Fatty liver and the metabolic syndrome among Shanghai adults. Eur J Gastroenterol Hepatol 2005; 20: 1825-32
126. Gu, D, Reynolds, K and Duan, X et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003; 46: 1190-8
127. Pan, XR, Yang, WY and Li, GW et al. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 1997; 20: 1664-9
128. Yang, W, Lu, J and Weng, J et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 1090-101
129. Friberg, E, Orsini, N and Mantzoros, CS et al. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007; 50: 1365-74
130. Huxley, R, Ansary-Moghaddam, A and Berrington de Gonzalez, A et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92: 2076-83
131. Larsson, SC, Mantzoros, CS and Wolk, A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 2007; 121: 856-62
132. Larsson, SC, Orsini, N and Wolk, A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97: 1679-87